雷聲亮醫生 - 腎病科
腎病科專科醫生
重點資料
- 醫務委員會註冊已驗證
- 雙語診症廣東話 · 英語
- 1 個診所地點上環
- 腎病科專科醫生香港大學內外全科醫學士 · 英國皇家內科醫學院院士 · 香港內科醫學院院士 · 1990 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
雷聲亮醫生是上環的腎病科醫生，診症語言包括廣東話、英語。
學歷
腎病科專科醫生
- 香港大學內外全科醫學士1990
- 英國皇家內科醫學院院士1993
- 香港醫學專科學院院士(內科)1998
- 香港大學醫學博士2003
地點
保險計劃
常見問題
雷聲亮醫生好嗎？
雷聲亮醫生是上環的腎病科醫生，診症語言包括廣東話、英語。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
雷聲亮醫生是做什麼的？
雷聲亮醫生是腎病科醫生。
雷聲亮醫生在哪裡看診？
雷聲亮醫生於上環應診。
雷聲亮醫生可以用甚麼語言應診？
雷聲亮醫生可以用廣東話、英語應診。
研究及論文
共 28 篇，顯示最近 12 篇
按論文主題篩選
主題由同一批 PubMed 論文的醫學分類整理，不代表醫生提供相關診治服務。
- The Relationship of Osmolality and Kidney Outcomes in Patients with Autosomal Dominant Polycystic Kidney Disease.Kidney360 · 2026
- Kidney Disease: Improving Global Outcomes Summit Recommendations on Implementation of Diabetes Management in CKD: From Primary to Data-Driven Collaborative Care.Kidney international reports · 2025
- A 30-year case study of local implementation of global guidelines for data-driven diabetes management starting with the Hong Kong Diabetes Register.The Lancet regional health. Western Pacific · 2025
- Expanded Hemodialysis with Theranova Compared with Conventional High-Flux Hemodialysis: Prospective Randomized 12-Month Study.Kidney360 · 2025
- Add-on Rehmannia-6-Based Chinese Medicine in Type 2 Diabetes and CKD: A Multicenter Randomized Controlled Trial.Clinical journal of the American Society of Nephrology : CJASN · 2023
- Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact.Nephrology (Carlton, Vic.) · 2022
- Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID-19: a self-controlled case series study.Alimentary pharmacology & therapeutics · 2022
- Editorial: liver and kidney injury from remdesivir-an issue not as much as its purpose. Authors' reply.Alimentary pharmacology & therapeutics · 2022
- A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
- Blue-green urine.Nephrology (Carlton, Vic.) · 2021
- Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.BMC nephrology · 2020
- Anti-fibrotic effect of decorin in peritoneal dialysis and PD-associated peritonitis.EBioMedicine · 2020
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明